Minerva Neurosciences, Inc. (NERV): Net Income
-$293.42M
Year ended 2025-12-31
-$394.35M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$293.42M | n/m | 2026-03-11, From 2025-01-01 |
| 2024-12-31 | $1.44M | n/m | 2026-03-11, From 2024-01-01 |
| 2023-12-31 | -$30.01M | n/m | 2025-02-25, From 2023-01-01 |
| 2022-12-31 | -$32.11M | n/m | 2024-02-22, From 2022-01-01 |
| 2021-12-31 | -$49.91M | n/m | 2023-03-08, From 2021-01-01 |
| 2020-12-31 | $1.94M | n/m | 2022-03-01, From 2020-01-01 |
| 2019-12-31 | -$72.18M | n/m | 2021-03-08, From 2019-01-01 |
| 2018-12-31 | -$50.17M | n/m | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | -$31.52M | n/m | 2019-03-12, From 2017-01-01 |
| 2016-12-31 | -$31.05M | n/m | 2018-03-12, From 2016-01-01 |
| 2015-12-31 | -$27.08M | n/m | 2018-03-12, From 2015-01-01 |
| 2014-12-31 | -$56.90M | n/a | 2017-03-13, From 2014-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | 2025-12-31 | -$293.42M | n/m |
| iBio, Inc. (IBIO) | 2026-06-30 | -$33.04M | n/m |
| Citius Oncology, Inc. (CTOR) | 2025-09-30 | -$24.76M | n/m |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | -$33.50M | n/m |
| Journey Medical Corp (DERM) | 2025-12-31 | -$11.43M | n/m |
| Relmada Therapeutics, Inc. (RLMD) | 2025-12-31 | -$57.39M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | -$4.60M | n/m |
| Tenax Therapeutics, Inc. (TENX) | 2025-12-31 | -$52.60M | n/m |
| Immix Biopharma, Inc. (IMMX) | 2025-12-31 | -$29.44M | n/m |
Compare NERV, IBIO, CTOR, ABUS side by side · Screen every company in Pharmaceutical Preparations ↗